Generate a tailored SOP for Dr. Maria Bergamasco. Improve your application with a focused, well-structured draft.
Maria Bergamasco received her PhD in biomedical research in 2020 from the University of Melbourne. During her doctoral work, she conducted her thesis research at the Walter and Eliza Hall Institute under the supervision of Professor Anne Voss and Associate Professor Tim Thomas, focusing on the roles of histone acetyltransferase genes in brain development and intellectual disability. In 2024, she transitioned to the Neely lab at the Charles Perkins Institute at the University of Sydney. Her research aims to improve the understanding of neurological disease disorder pathology and to develop novel treatment options. Additionally, she has experience as a scientific demonstrator at the Gene Technology Access Center (GTAC) in Melbourne. Her research interests encompass the role of chromatin modifiers in pain perception, the impact of environmental toxins on brain development, and strategies for addressing age-related cognitive decline.
Gene Technology Access Center • Melbourne
Provided demonstrations in gene technology to students and researchers.
Neely Lab, Charles Perkins Institute • Sydney
Investigating the pathology of neurological diseases and potential treatment options.
This entry applies to Faculty of Science PhD programs including Departments such as Life and Environmental Sciences, Physics, Chemistry, and Mathematics and Statistics.